Amplitude Surgical Announces Its Results for the First Half of 2022-23

Sales of €45.2 Million and EBITDA of €11.7 Million - Seite 4

The net cash flow generated by operating activity was a positive €1.0 million over the half, compared with a positive €1.7 million in the first half of 2021-22.

Investments totaled €9.3 million in the first half of 2022-23, versus €4.9 million in H1 2021-22.

At the end of December 2022, the Group had cash and cash equivalents of €11.0 million and Net Financial debt of €128.3 million.

Availability of the financial report

Amplitude Surgical has made its half-year report to December 31, 2022 available to the public and filed it with the AMF French stock market authorities.

This half-year financial report can be found on Amplitude Surgical’s website at www.amplitude-surgical.com/fr, in the “Documentation / Financial Report” section.

Next financial press release:
Sales for the first 9 months of 2022-23, on Thursday April 20, 2023 (after market).

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2022, Amplitude Surgical had a workforce of 460 employees and recorded sales of nearly 104.8 million euros (including foot and ankle activity and before application of IFRS 5).

View source version on businesswire.com: https://www.businesswire.com/news/home/20230322005521/en/

The Amplitude Surgical Stock at the time of publication of the news with a raise of +1,44 % to 3,165EUR on Lang & Schwarz stock exchange (22. März 2023, 17:53 Uhr).